CSI Market
Sign In | Register

Emergent Biosolutions Inc (EBS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EBS Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Emergent Biosolutions Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/EBS/balance-sheets
https://api.csimarket.com/api/v1/companies/EBS/fundamentals
https://api.csimarket.com/api/v1/companies/EBS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent175.70
Restricted Cash1.20
Cash & Short-term Investments175.00
Accounts receivable77.50
Other Receivables16.60
Inventories280.90
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current22.90
Total Current Assets558.20
Equipment/Property/Plant Net474.90
Intangible Assets252.50
Deferred, Prepaid and Other Assets, Noncurrent6.60
Other Assets, Noncurrent0.00
Restricted Cash Current1.20
Total Assets995.20
Liabilities
Accounts Payable, Current AC52.00
Accrued Liabilities, Current34.10
Other Liabilities, Current31.60
Accrued Income Taxes, Current TA4.30
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities122.00
Long-term debt514.30
Total Long-term Debt514.30
Other liabilities, Noncurrent45.70
Contract With Customer Liability Current12.20
Total Liabilities682.00
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock956.60
Retained Earnings / Accumulated Deficit-365.90
Accumulated Other Comprehensive Income-6.90
Other Equity-6.90
Common Stockholder's Equity313.20
Total Stockholder's Equity313.20
Liabilities & Stockholder's Equity995.20
4 historic quarters locked

Sign in to unlock the full Emergent Biosolutions Inc balance sheet history.

Sign In Create Free Account

About Emergent Biosolutions Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 2, 2026
  • Source: ebs-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001367644-26-000112

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI